← Back to Search
Going Even Smaller: Engineering Sub-5 Nm Nanoparticles For Improved Delivery, Biocompatibility, And Functionality.
Manman Xie, Y. Xu, J. Huang, Yuancheng Li, L. Wang, Lily Yang, Hui Mao
Published 2020 · Computer Science, Medicine
Download PDFAnalyze on Scholarcy
The rapid development and advances in nanomaterials and nanotechnology in the past two decades have made profound impact in our approaches to individualized disease diagnosis and treatment. Nanomaterials, mostly in the range of 10-200 nm, developed for biomedical applications provide a wide range of platforms for building and engineering functionalized structures, devices, or systems to fulfill the specific diagnostic and therapeutic needs. Driven by achieving the ultimate goal of clinical translation, sub-5 nm nano-constructs, in particular inorganic nanoparticles such as gold, silver, silica, and iron oxide nanoparticles, have been developed in recent years to improve the biocompatibility, delivery and pharmacokinetics of imaging probes and drug delivery systems, as well as in vivo theranostic applications. The emerging studies have provided new findings that demonstrated the unique size-dependent physical properties, physiological behaviors and biological functions of the nanomaterials in the range of the sub-5 nm scale, including renal clearance, novel imaging contrast, and tissue distribution. This advanced review attempts to introduce the new strategies of rational design for engineering nanoparticles with the core sizes under 5 nm in consideration of the clinical and translational requirements. We will provide readers the update on recent discoveries of chemical, physical, and biological properties of some biocompatible sub-5 nm nanomaterials as well as their demonstrated imaging and theranostic applications, followed by sharing our perspectives on the future development of this class of nanomaterials. This article is categorized under: Diagnostic Tools > in vivo Nanodiagnostics and Imaging Implantable Materials and Surgical Technologies > Nanomaterials and Implants.
This paper references
Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.
M. Benezra (2011)
Glomerular Barrier Behaves As an Atomically Precise Bandpass Filter in a Sub-nanometer Regime
Bujie Du (2017)
Glutathione-Mediated Clearable Nanoparticles Based on Ultrasmall Gd2O3 for MSOT/CT/MR Imaging Guided Photothermal/Radio Combination Cancer Therapy.
Yu Cheng (2019)
Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine.
A. Burns (2009)
A multifunctional nanoplatform for imaging, radiotherapy, and the prediction of therapeutic response.
Casey McQuade (2015)
The History of Nanoscience and Nanotechnology: From Chemical–Physical Applications to Nanomedicine
S. Bayda (2019)
A pilot study in non-human primates shows no adverse response to intravenous injection of quantum dots.
L. Ye (2012)
Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Maria Ahrén (2010)
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
H. Wei (2017)
Biomolecular coronas provide the biological identity of nanosized materials.
M. Monopoli (2012)
Improving the Magnetic Resonance Imaging Contrast and Detection Methods with Engineered Magnetic Nanoparticles
Jing Huang (2012)
Renally Excretable and Size-Tunable Silver Sulfide Nanoparticles for Dual-Energy Mammography or Computed Tomography.
Jessica C. Hsu (2019)
Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes.
B. Chithrani (2007)
Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics.
Chen Zhou (2012)
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
D. Thorek (2005)
Renal clearance of quantum dots
H. Choi (2007)
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
W. D. de Jong (2008)
Metabolism of nanomaterials in vivo: blood circulation and organ clearance.
Bing Wang (2013)
Integrins in cancer: biological implications and therapeutic opportunities
J. S. Desgrosellier (2010)
Disappearance of the Superionic Phase Transition in Sub-5 nm Silver Iodide Nanoparticles.
T. Yamamoto (2017)
Transport and interactions of nanoparticles in the kidneys
Bujie Du (2018)
Safety Report of Ferumoxytol for Magnetic Resonance Imaging in Children and Young Adults
Anne M Muehe (2016)
Clearance Pathways and Tumor Targeting of Imaging Nanoparticles.
M. Yu (2015)
Relaxometric and magnetic characterization of ultrasmall iron oxide nanoparticles with high magnetization. Evaluation as potential T1 magnetic resonance imaging contrast agents for molecular imaging.
E. Taboada (2007)
Radioprotective effects of ultra-small citrate-stabilized cerium oxide nanoparticles in vitro and in vivo
A. G. Popov (2016)
Nano based drug delivery systems: recent developments and future prospects
J. Patra (2018)
T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents.
Zijian Zhou (2017)
Surface engineering of inorganic nanoparticles for imaging and therapy.
Jutaek Nam (2013)
Silver nanoparticle protein corona and toxicity: a mini-review
N. Duran (2015)
Smart cancer nanomedicine
R. van der Meel (2019)
Imaging Nano-Bio Interactions in the Kidney: Toward a Better Understanding of Nanoparticle Clearance.
Junqing Wang (2018)
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
H. Cabral (2011)
Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles.
F. Chen (2016)
Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography.
Xiao-yu Zheng (2017)
Permeation of macromolecules into the renal glomerular basement membrane and capture by the tubules
Marlon G. Lawrence (2017)
Nanoparticle delivery of cancer drugs.
A. Wang (2012)
Bioapplications of renal-clearable luminescent metal nanoparticles.
Lingshan Gong (2017)
Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.
C. David (2016)
Targeting orthotopic gliomas with renal-clearable luminescent gold nanoparticles
Chuanqi Peng (2017)
Theranostic nanoparticles with controlled release of gemcitabine for targeted therapy and MRI of pancreatic cancer.
G. Lee (2013)
Synthesis, Characterization, and Application of Ultrasmall Nanoparticles
Byung Hyo Kim (2014)
In vitro biocompatibility study of sub-5 nm silica-coated magnetic iron oxide fluorescent nanoparticles for potential biomedical application
S. Foglia (2017)
In vivo biodistribution of nanoparticles.
Joao Paulo Mattos Almeida (2011)
In vivo degeneration and the fate of inorganic nanoparticles.
Neus Feliu (2016)
Optimized metal-organic-framework nanospheres for drug delivery: evaluation of small-molecule encapsulation.
J. Zhuang (2014)
Biointeractions of ultrasmall glutathione-coated gold nanoparticles: effect of small size variations.
A. A. Sousa (2016)
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors.
Qin Dai (2018)
T1‐weighted ultrashort echo time method for positive contrast imaging of magnetic nanoparticles and cancer cells bound with the targeted nanoparticles
L. Zhang (2011)
Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1-T2 Switchable Magnetic Resonance Imaging Contrast.
L. Wang (2017)
Factors relating to the biodistribution & clearance of nanoparticles & their effects on in vivo application.
Yanchun Wei (2018)
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
Water-soluble iron oxide nanoparticles with high stability and selective surface functionality.
Yaolin Xu (2011)
Integrating Nanotechnology into Cancer Care.
P. Grodzinski (2019)
Serum protein adsorption and excretion pathways of metal nanoparticles.
Rodrigo D. Vinluan (2015)
Cancer active targeting by nanoparticles: a comprehensive review of literature
Remon Bazak (2014)
Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models.
L. Chou (2012)
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
C. Choi (2009)
Effects of nanoparticle size on cellular uptake and liver MRI with polyvinylpyrrolidone-coated iron oxide nanoparticles.
J. Huang (2010)
In vivo fluorescence imaging with Ag2S quantum dots in the second near-infrared region.
Guosong Hong (2012)
Ultrashort Echo Time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models
L. Wang (2014)
Facile non-hydrothermal synthesis of oligosaccharides coated sub-5 nm magnetic iron oxide nanoparticles with dual MRI contrast enhancement effect.
Jing Huang (2014)
Physiological stability and renal clearance of ultrasmall zwitterionic gold nanoparticles: Ligand length matters
Xuhui Ning (2017)
Current and potential imaging applications of ferumoxytol for magnetic resonance imaging.
Gerda B Tóth (2017)
Improving sensitivity and specificity of capturing and detecting targeted cancer cells with anti-biofouling polymer coated magnetic iron oxide nanoparticles.
Run Lin (2017)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface.
A. Salvati (2013)
Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination.
Y. Zhang (2016)
Sub 5 nm magnetite nanoparticles: Synthesis, microstructure, and magnetic properties
J. H. Wu (2007)
Probing and Enhancing Ligand-Mediated Active Targeting of Tumors Using Sub-5 nm Ultrafine Iron Oxide Nanoparticles
Yaolin Xu (2020)
Contribution of Kupffer cells to liposome accumulation in the liver.
Emma Samuelsson (2017)
Big Potential from Small Agents: Nanoparticles for Imaging-Based Companion Diagnostics.
E. Ehlerding (2018)
A facile synthesis, in vitro and in vivo MR studies of d-glucuronic acid-coated ultrasmall Ln₂O₃ (Ln = Eu, Gd, Dy, Ho, and Er) nanoparticles as a new potential MRI contrast agent.
Krishna Kattel (2011)
Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
Byung Hyo Kim (2011)
Biodistribution, Clearance, and Long-Term Fate of Clinically Relevant Nanomaterials.
Joël Bourquin (2018)
Magnetic and pH-sensitive nanoparticles for antitumor drug delivery.
Shufang Yu (2013)
Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency.
Edward A. Sykes (2014)
Cancer nanomedicines: closing the translational gap
A. Gabizon (2015)
Ultrasmall Renally-clearable Silica Nanoparticles Target Prostate Cancer.
F. Chen (2019)
Molecularly stabilised ultrasmall gold nanoparticles: synthesis, characterization and bioactivity.
Annika Leifert (2013)
Nanotheranostics for personalized medicine
T. Kim (2013)
Mechanism of hard nanomaterial clearance by the liver
Kim M. Tsoi (2016)
Interactions of Renal-Clearable Gold Nanoparticles with Tumor Microenvironments: Vasculature and Acidity Effects.
M. Yu (2017)
The biodistribution of gold nanoparticles designed for renal clearance.
Christophe Alric (2013)
Continuous flow synthesis of ultrasmall gold nanoparticles in a microreactor using trisodium citrate and their SERS performance
H. Huang (2018)
Multicenter Safety and Practice for Off-Label Diagnostic Use of Ferumoxytol in MRI.
Kim-Lien Nguyen (2019)
IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
H. Zhou (2015)
Active-target T1-weighted MR Imaging of Tiny Hepatic Tumor via RGD Modified Ultra-small Fe3O4 Nanoprobes
Zhengyang Jia (2016)
Solid phase metallurgy strategy to sub-5 nm Au-Pd and Ni-Pd bimetallic nanoparticles with controlled redox properties.
Y. Tang (2014)
Ultrasmall Glutathione-Protected Gold Nanoclusters as Next Generation Radiotherapy Sensitizers with High Tumor Uptake and High Renal Clearance
X. Zhang (2015)
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities.
R. Jin (2016)
PEG-b-AGE Polymer Coated Magnetic Nanoparticle Probes with Facile Functionalization and Anti-fouling Properties for Reducing Non-specific Uptake and Improving Biomarker Targeting.
Yuancheng Li (2015)
One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
G. Wang (2014)
Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Dongyu Chen (2017)
The effect of nanoparticle size, shape, and surface chemistry on biological systems.
Alexandre Albanese (2012)
Cooperativity Principles in Self-Assembled Nanomedicine.
Y. Li (2018)
Ferumoxytol for the treatment of iron deficiency
M. Rosner (2011)
Nanoparticle imaging of integrins on tumor cells.
X. Montet (2006)
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.
H. Arami (2015)
Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles: From Mice to Non-human Primates.
Jing Xu (2018)
Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging.
Y. Jun (2005)
Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density.
Shaoheng Tang (2016)
Principles of nanoparticle design for overcoming biological barriers to drug delivery
E. Blanco (2015)
Ultrasmall Water-Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast Agents
Z. Li (2012)
Thioether-Polyglycidol as Multivalent and Multifunctional Coating System for Gold Nanoparticles.
Susanne Feineis (2018)
Renal clearable catalytic gold nanoclusters for in vivo disease monitoring
C. Loynachan (2019)
Nanoparticle therapeutics: an emerging treatment modality for cancer
M. Davis (2008)
Cancer-Targeting Ultrasmall Silica Nanoparticles for Clinical Translation: Physicochemical Structure and Biological Property Correlations.
F. Chen (2017)
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology.
Uma Prabhakar (2013)
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application.
Y. Wáng (2011)
Overcoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
O. S. Thomas (2019)
The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction.
Nazanin Hoshyar (2016)
Nanoparticle Uptake: The Phagocyte Problem.
Heather Herd Gustafson (2015)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
X. Huang (2010)